+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 50Years
FEMALE
ID05386615

Registry Study on Pregnancy Outcomes After Exablate Treatment for Symptomatic Uterine Fibroids in Women Aged 18 to 50

Led by InSightec · Updated on 2025-04-30

200

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to collect information about pregnancy outcomes and fibroid treatment history in women who have been treated with Exablate for symptomatic uterine fibroids. The study focuses on observing the effects of the Exablate treatment on potential pregnancies in this group over a two-year period after treatment. The goal is to gather data for labeling updates and overall safety monitoring. Participants in this study have undergone a commercial Exablate procedure, which uses MR-guided focused ultrasound to treat uterine fibroids. This is an observational study, meaning no additional treatment or intervention is provided as part of the study. Instead, researchers collect data from patients who have already received the Exablate treatment. During the study, participants health and pregnancy outcomes are tracked for an average of two years following their treatment. Researchers monitor for any adverse events and collect relevant clinical information. The total participation time is about two years after the Exablate procedure, during which the safety and pregnancy effects of the treatment are assessed.

CONDITIONS

Brief Title

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

Research Team

N

Nadir Alikacem

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here